by Claudia Li | Sep 3, 2024 | Press Releases
Press release DiaCarta Helps Communities Scale Up Their MPOX Testing Efforts with Its Simple, Reliable, and FDA-EUA-Approved MPOX Testing Kits FollowFollow DiaCarta, Inc., an experienced in-vitro diagnostics (IVD) company that provided COVID-19 testing kits during the...
by Claudia Li | Jun 27, 2024 | Press Releases
Press release DiaCarta and Capstone Health Alliance Collaborate to Bring Revolutionary Diagnostic Tests to Enhance Patient Care FollowFollow DiaCarta, Inc. (“DiaCarta”), a pioneer in developing innovative molecular technologies to transform patient care by...
by Claudia Li | Mar 11, 2024 | Press Releases
Press release Florida Selects DiaCarta’s cfDNA Test (RadTox™) for Statewide Use to Detect Early Response of Cancer Treatment FollowFollow DiaCarta, a leading molecular diagnostics company specializing in personalized patient care through liquid biopsy, proudly...
by Claudia Li | Mar 4, 2024 | Press Releases
Press release DiaCarta Announces That the Oncuria® Bladder Cancer Tests Receive Medicare Coverage Effective January 1, 2024 FollowFollow DiaCarta proudly announced that the Oncuria® Bladder Cancer Tests, developed by Nonagen Bioscience and validated by DiaCarta as a...
by Claudia Li | Feb 27, 2024 | Press Releases
Press release DiaCarta, Inc. and OncoAssure Ltd. Collaborate to Launch Prostate Cancer Lab Developed Test FollowFollow DiaCarta, Inc. (“DiaCarta”), a pioneer in molecular diagnostic test development for cancer and infectious diseases, today announced that...
Recent Comments